Leonardo Biosystems, Inc.: Series A $1.25M

Posted in I - Series A, Q - 4Q11, R - SOUTH WEST, X - Delivery, XX - TX

Leonardo Biosystems (Houston, TX) a development-stage biopharmaceutical company focused on drug delivery technology, closed a $1.25M Series A financing, bringing the total round to $2.5M. Participants include Texas Emerging Technology Fund.

Inova Labs, Inc.: Series B $17.5M

Posted in I - Series B, Q - 4Q11, R - SOUTH WEST, X - Device (COPD), XX - TX

Inova Labs (Austin, TX) a medical device company focused on the development, manufacturing, and worldwide distribution of medical devices used to treat Chronic Obstructive Pulmonary Disease, closed a $17.5 million in Series B financing. Participants include Latterell Venture Partners, Gilde Healthcare Partners and Three Arch Partners.

nanoMR, Inc.: Series B $13M

Posted in I - Series B, Q - 3Q11, R - SOUTH WEST, X - Device (Diagnostic), XX - NM

nanoMR (Albuquerque, NM) a development stage medical device focused on a immunomagnetic capture system for the blood culture market, closed a $13M Series B financing. Participants include Excel Venture Management, Healthcare Ventures, vSpring Capital, Dow Chemical Company and Sun Mountain Capital.
Thanx for your patience as we catch-up.

Affinium Pharmaceuticals, Inc.: Series B $15M

Posted in I - Series B, Q - 3Q11, R - SOUTH WEST, X - Antibacterial, X - Antiinfective, X - MRSA, XX - TX

Affinium Pharmaceuticals (Austin, TX) a clinical-stage specialty pharmaceutical company focused on small molecule antibiotics targeting staph and MRSA infections, closed a $15M Series B financing. Participants include SV Life Sciences, Genesis Capital Partners, Forward Ventures and Ontario Emerging Technologies Fund.
Thanx for your patience as we catch-up.

AliveCor, Inc.: Series A $3M

Posted in I - Series A, Q - 3Q11, R - SOUTH WEST, X - Device (ECG), X - Device (iPhone), XX - OK

AliveCor (Oklahoma City, OK) a development-stage medical device company focusing o mobile electrocardiogram recorder, closed a $3M Series A financing. Participants include Burrill & Company, Qualcomm Ventures and Oklahoma Life Science Fund.
Thanx for your patience as we catch-up.

Teladoc, Inc.: Series D $18.6M

Posted in I - Series D, Q - 3Q11, R - SOUTH WEST, X - TeleMedicine, XX - TX

Teladoc (Dallas, TX) a commercial-stage on-demand telehealth services provider, closed a $18.6M Series D financing. Participants include Kleiner Perkins, Cardinal Partners, HLM Venture Partners, Trident Capital and New Capital Partners.

Cytovance Biologics, Inc.: Series B $22.5M

Posted in I - Series B, Q - 1Q11, R - SOUTH WEST, X - CMO, XX - OK

Cytovance (Oklahoma City, OK) a contract manufacturer of mammalian and microbial biologics, closed a $22.5M Series B financing. Participants include Great Point Partners.

HTG, Inc.: Series D $15.7M

Posted in I - Series D, Q - 1Q11, R - SOUTH WEST, X - Device (Diagnostic), X - mRNA, X - miRNA, XX - AZ

HTG (Tuscon, AZ) a commercial-stage molecular technology company focused on gene expression profiling, miRNA and mRNA measurement, translational medicine and diagnostic applications, closed a $15.7M Series D financing. Participants include Novo Ventures, Fletcher Spaght Ventures, Merck Capital Ventures, Solstice Capital and Valley Ventures.

Ulthera, Inc.: Series C $10.5M

Posted in I - Series C, Q - 1Q11, R - SOUTH WEST, X - Device (Aesthetics), XX - AZ

Ulthera (Mesa, AZ) a commercial-stage medical device company focused on ultrasound technology in the aesthetics market, closed a $10.5M Series C financing. Participants include New Enterprise Associates and Apposite Capital.

ViroXis Corp.: Series A $2.5M

Posted in I - Series A, Q - 4Q10, R - SOUTH WEST, X - Antiviral, X - HPV, XX - TX

ViroXis (San Antonio, TX) a development stage biopharmaceutical company focused on antiviral treatment of HPV associated skin warts, closed a $2.5M Series A financing. Participants include Texas Emerging Technology Fund.

WebPT, Inc.: Series A $1M

Posted in I - Series A, Q - 4Q10, R - SOUTH WEST, X - TeleMedicine, XX - AZ

WebPT (Phoenix, AZ) a commercial-stage web-based electronic medical records systems for physical therapists, closed a $1M Series A financing. Participants include Canal Partners.

DICOM Grid, Inc.: Series A $7.5M

Posted in I - Series A, Q - 4Q10, R - SOUTH WEST, X - Bioinformatics, X - Imaging, X - TeleMedicine, XX - AZ

DICOM Grid (Phoenix, AZ) a development-stage bioinformatics company focused on the development of medical imaging software, closed a $7.5M Series A financing. Participants include Canaan Partners and CHL Medical Partners.

IDEV Technologies, Inc.: Series D $46M

Posted in I - Series D, Q - 4Q10, R - SOUTH WEST, X - Device (Stent), XX - TX

IDEV Technologies (Webster, TX) a clinical-stage medical device company focused on endovascular and interventional stents, closed a $46M Series D financing. Participants include Piper Jaffray, PTV Sciences, Bay City Capital, RiverVest Venture Partners and Heron Capital.

« Previous Entries

to top of page...